Schuster SJ, Bishop MR, Tam C, et al. Sustained disease control for adult patients with relapsed or refractory diffuse large B-cell lymphoma: an updated analysis of Juliet, a global pivotal phase 2 trial of tisagenlecleucel. ASH Annual Meeting and Exposition 2018, abstract 1684.
FDA versnelt goedkeuring copanlisib bij recidiverend folliculair lymfoom
sep 2017 | Lymfoom